Table 3 Baseline and follow-up results in the three different treatment groups

8.3 (± 1.4)

9.1 (± 1.7)

8.6 (± 1.7)

.078

6.7 (± 0.8)

7.1 (± 1.1)

7.7 (± 1.2)

< .001^c

-1.6 (± 1.7)*

-1.8 (± 1.8)*

-0.9 (± 1.7)*

< .001^1bc

32.9 (± 6.5)

32.4 (± 5.8)

35.7 (± 7.9)

.051

31.2 (± 6.6)

31.3 (± 5.2)

35.0 (± 7.9)

.010^bc

-1.7 (± 1.5)*

-1.1 (± 1.9)*

-0.7 (± 2.6)*

.054¹

51.2 (± 12.2)

49.2 (± 9.8)

45.8 (± 8.3)

.040 ^c

53.6 (± 12.3)

46.2 (± 9.9)

44.5 (± 8.0)

< .001^bc

2.4 (± 14.8)^ns

-3.0 (± 7.0)*

-1.3 (± 8.0) ^ns

.003^1ac

41.8 (± 12.2)

41.0 (± 9.1)

37.4 (± 10.4)

.063

43.4 (± 11.8)

37.9 (± 8.7)

35.7 (± 7.4)

.002^bc

1.6 (± 15.0) ^ns

-3.1 (± 6.5)*

-1.7 (± 7.3) ^ns

.006^1ac

10.4 (± 2.5)

9.5 (± 2.2)

9.4 (± 1.9)

.098

11.0 (± 2.8)

9.4 (± 2.2)

9.6 (± 2.0)

.008^bc

0.6 (± 3.0) ^ns

-0.1 (± 2.2) ^ns

0.2 (± 2.4) ^ns

.042^1ac

27.7 (± 17.8)

33.8 (± 18.4)

28.2 (± 14.1)

.166

21.8 (± 13.9)

26.5 (± 15.6)

24.6 (± 16.9)

.384

-5.9 (± 15.8) ^ns

-7.3 (± 14.9) *

-3.6 (± 15.1) ^ns

.285¹

16.4 (± 6.0)

13.6 (± 6.3)

12.9 (± 6.4)

.056

16.7 (± 5.6)

15.6 (± 5.8)

13.9 (± 6.0)

.129

0.3 (± 5.7) ^ns

2.0 (± 4.9) *

1.0 (± 5.7) ^ns

.389¹

11.7 (± 8.2)

16.1 (± 10.2)

17.8 (± 10.9)

.039^c

10.8 (± 7.9)

11.9 (± 9.8)

16.4 (± 9.8)

.019

-0.9 (± 7.1) ^ns

-4.2 (± 6.0) *

-1.4 (± 8.5) ^ns

.045^1b

37.7 (± 9.7)

41.3 (± 12.0)

41.6 (± 8.4)

.227

36.4 (± 8.3)

40.2 (± 10.6)

40.7 (± 9.9)

.138

-1.3 (± 5.9) ns

-1.1 (± 8.2) ns

-0.9 (± 7.2) ns

.622¹